B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ERBB2

MOLECULAR TARGET

erb-b2 receptor tyrosine kinase 2

UniProt: P04626NCBI Gene: 206474 compounds

ERBB2 (erb-b2 receptor tyrosine kinase 2) is targeted by 74 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ERBB2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1paclitaxel7.171301
2tamoxifen5.88358
3gefitinib5.67290
4erlotinib5.55256
5imatinib5.47236
6osimertinib5.03152
7sb 2035804.92136
8ibrutinib4.86128
9lapatinib4.84126
10alvocidib4.5291
11amiodarone4.5190
12foretinib4.3476
13vandetanib4.3073
14caffeic acid phenethyl ester4.2569
15bosutinib4.0858
16fluphenazine3.9149
17brigatinib3.8144
18neratinib3.6638
19canertinib3.5333
20pelitinib3.5032
21candesartan3.4731
22tae 6843.4330
23acalabrutinib3.2224
24dacomitinib anhydrous3.1422
25defosbarasertib2.8917
26bithionol2.8917
27pu h712.8917
28benzodefchrysene2.8917
29cediranib2.8316
30masitinib2.7715
31closantel2.7114
32ebastine2.6413
33zanubrutinib2.5612
34cp 7247142.5612
35poziotinib2.4811
36tyrphostin 472.4811
37cudc 1012.4010
38benzethonium chloride2.4010
39tak 2852.4010
40aee 7882.309
41cetylpyridinium bromide2.208
42iodoquinol2.208
43mubritinib2.208
44tg100 1152.087
45enclomiphene2.087
46canertinib dihydrochloride2.087
47lapatinib ditosylate2.087
48tyrphostin ag 8792.087
49maleimide1.956
50bastadin 71.956

Showing top 50 of 74 compounds. Use the BiohacksAI search to explore all ERBB2 modulators.

About ERBB2 as a Drug Target

ERBB2 (erb-b2 receptor tyrosine kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 74 compounds with documented ERBB2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ERBB2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.